 |
 |
|
 |
| SPOT ON | |
ACCORD study - treatment guidelines for type 2 diabetes on trial | |
| NEW ON THE MARKET | |
Pneumococcal vaccines PREVENAR 13, SYNFLORIX | |
| READERS' QUESTIONS AND COMMENTS | |
Bipolar disorder: avoidable turnaround of EMA | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Diabetes prevention study NAVIGATOR | |
| IN BRIEF | |
Quality tests of oxycodone preparations | |
 |
Contamination of rota virus vaccine: avoid ROTARIX |
| CURRENT ADR NETWORK REPORT | |
Uzara root extract (UZARA) and facial oedema | |
| SIDE EFFECTS | |
Fatal renal failure due to bisphosphonate zoledronate | |
|
© arznei-telegramm 4/2010 | ||
 |  | |